UK Women's Health Market Size & Outlook, 2026-2033

The women's health market in UK is expected to reach a projected revenue of US$ 3,424.9 million by 2033. A compound annual growth rate of 4.6% is expected of UK women's health market from 2026 to 2033.
Revenue, 2025 (US$M)
$2,330.1
Forecast, 2033 (US$M)
$3,424.9
CAGR, 2026 - 2033
4.6%
Report Coverage
UK

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK women's health market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK women's health market highlights

  • The UK women's health market generated a revenue of USD 2,330.1 million in 2025 and is expected to reach USD 3,424.9 million by 2033.
  • The UK market is expected to grow at a CAGR of 4.6% from 2026 to 2033.
  • In terms of segment, contraceptives was the largest revenue generating application in 2025.
  • Menopause is the most lucrative application segment registering the fastest growth during the forecast period.


Women's health market data book summary

Market revenue in 2025USD 2,330.1 million
Market revenue in 2033USD 3,424.9 million
Growth rate4.6% (CAGR from 2026 to 2033)
Largest segmentContraceptives
Fastest growing segmentMenopause
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationHormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, UK accounted for 4.4% of the global women's health market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany women's health market is projected to lead the regional market in terms of revenue in 2033.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 3,424.9 million by 2033.

Contraceptives was the largest segment with a revenue share of 29.82% in 2025. Horizon Databook has segmented the UK women's health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2021 to 2033.


The NHS has identified the average age of menopause in women as 51 years in the UK, except for women who enter menopause before 40 years of age or even in their 30s. It estimated that around 13 million women, or around one-third of the female population in the UK, were perimenopausal or menopausal.

Considering the large target population, researchers are innovating products to ease the transition of women through menopause. The high demand for women’s health drugs and devices in this country is responsible for its current market share. Moreover, the UK has a large population of young women.

According to the World Bank, in 2022, 21.2 million women are in the age group of 15 to 64 years in the country. This large demographic substantially increases the demand for women’s health products and treatments related to contraceptives, hormonal infertility, endometriosis, polycystic ovary syndrome, and others.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Companies

Name Profile # Employees HQ Website
Apothecus View profile 11-50 Hicksville, New York, United States, North America https://apothecus.com
Blairex Laboratories View profile 101-250 Columbus, Indiana, United States, North America http://www.blairex.com
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

UK women's health market size, by application, 2021-2033 (US$M)

UK Women's Health Market Outlook Share, 2025 & 2033 (US$M)

UK women's health market size, by application, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online